Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin. 2018;68:394–424.

PubMed  Google Scholar 

Center MM, Jemal A, Lortet-Tieulent J, Ward E, Ferlay J, Brawley O, et al. International variation in prostate cancer incidence and mortality rates. Eur Urol. 2012;61:1079–92.

PubMed  Google Scholar 

Kuruma H, Egawa S. Words of Wisdom: re: international variation in prostate cancer incidence and mortality rates. Eur Urol. 2013;63:583–4.

PubMed  Google Scholar 

Lloyd T, Hounsome L, Mehay A, Mee S, Verne J, Cooper A. Lifetime risk of being diagnosed with, or dying from, prostate cancer by major ethnic group in England 2008–2010. BMC Med. 2015;13:171.

PubMed  PubMed Central  Google Scholar 

Bokhorst LP, Roobol MJ. Ethnicity and prostate cancer: the way to solve the screening problem? BMC Med. 2015;13:179.

PubMed  PubMed Central  Google Scholar 

Darcey E, Boyle T. Tobacco smoking and survival after a prostate cancer diagnosis: a systematic review and meta-analysis. Cancer Treat Rev. 2018;70:30–40.

PubMed  Google Scholar 

Rieken M, Shariat SF, Kluth LA, Fajkovic H, Rink M, Karakiewicz PI, et al. Association of Cigarette smoking and smoking cessation with biochemical recurrence of prostate cancer in patients treated with radical prostatectomy. Eur Urol. 2015;68:949–56.

PubMed  Google Scholar 

Darlington GA, Kreiger N, Lightfoot N, Purdham J, Sass-Kortsak A. Prostate cancer risk and diet, recreational physical activity and cigarette smoking. Chronic Dis Can. 2007;27:145–53.

PubMed  Google Scholar 

Liu F, Wang J, Wu HL, Wang H, Wang JX, Zhou R, et al. Leisure time physical activity and risk of prostate cancer: a dose-response meta-analysis. Minerva Urol e Nefrol = Italian J Urol Nephrol. 2018;70:152–61.

Google Scholar 

Bravo L. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev. 1998;56:317–33.

CAS  PubMed  Google Scholar 

Kampa M, Hatzoglou A, Notas G, Damianaki A, Bakogeorgou E, Gemetzi C, et al. Wine antioxidant polyphenols inhibit the proliferation of human prostate cancer cell lines. Nutr Cancer. 2000;37:223–33.

CAS  PubMed  Google Scholar 

Jones SB, DePrimo SE, Whitfield ML, Brooks JD. Resveratrol-induced gene expression profiles in human prostate cancer cells. Cancer Epidemiol Biomarkers Prev. 2005;14:596–604.

CAS  PubMed  PubMed Central  Google Scholar 

Wang TT, Schoene NW, Kim YS, Mizuno CS, Rimando AM. Differential effects of resveratrol and its naturally occurring methylether analogs on cell cycle and apoptosis in human androgen-responsive LNCaP cancer cells. Mol Nutr Food Res. 2010;54:335–44.

CAS  PubMed  Google Scholar 

Weinhold B. Epigenetics: the science of change. Environ Health Perspect. 2006;114:A160–7.

PubMed  PubMed Central  Google Scholar 

Mazzio EA, Soliman KF. Basic concepts of epigenetics: impact of environmental signals on gene expression. Epigenetics. 2012;7:119–30.

CAS  PubMed  PubMed Central  Google Scholar 

Cheung P, Lau P. Epigenetic regulation by histone methylation and histone variants. Mol Endocrinol. 2005;19:563–73.

CAS  PubMed  Google Scholar 

Marcu MG, Jung YJ, Lee S, Chung EJ, Lee MJ, Trepel J, et al. Curcumin is an inhibitor of p300 histone acetylatransferase. Med Chem (Shariqah United Arab Emirates)). 2006;2:169–74.

CAS  Google Scholar 

Vanacore D, Boccellino M, Rossetti S, Cavaliere C, D’Aniello C, Di Franco R, et al. Micrornas in prostate cancer: an overview. Oncotarget. 2017;8:50240–51.

PubMed  PubMed Central  Google Scholar 

Chiyomaru T, Yamamura S, Zaman MS, Majid S, Deng G, Shahryari V, et al. Genistein suppresses prostate cancer growth through inhibition of oncogenic microRNA-151. PLoS ONE. 2012;7:e43812.

CAS  PubMed  PubMed Central  Google Scholar 

Yang FQ, Liu M, Li W, Che JP, Wang GC, Zheng JH. Combination of quercetin and hyperoside inhibits prostate cancer cell growth and metastasis via regulation of microRNA-21. Mol Med Rep. 2015;11:1085–92.

CAS  PubMed  Google Scholar 

Sheth S, Jajoo S, Kaur T, Mukherjea D, Sheehan K, Rybak LP, et al. Resveratrol reduces prostate cancer growth and metastasis by inhibiting the Akt/MicroRNA-21 pathway. PLoS ONE. 2012;7:e51655.

CAS  PubMed  PubMed Central  Google Scholar 

Ferro M, Ungaro P, Cimmino A, Lucarelli G, Busetto GM, Cantiello F, et al. Epigenetic signature: a new player as predictor of clinically significant prostate cancer (PCa) in patients on active surveillance (AS). Journal [serial on the Internet]. 2017;18(6):1146.

Google Scholar 

Hatziapostolou M, Iliopoulos D. Epigenetic aberrations during oncogenesis. Cell Mol Life Sci. 2011;68:1681–702.

CAS  PubMed  PubMed Central  Google Scholar 

Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifications. Cell Res. 2011;21:381–95.

CAS  PubMed  PubMed Central  Google Scholar 

Aghdam SG, Ebrazeh M, Hemmatzadeh M, Seyfizadeh N, Shabgah AG, Azizi G, et al. The role of microRNAs in prostate cancer migration, invasion, and metastasis. J Cell Physiol. 2019;234:9927–42.

CAS  PubMed  Google Scholar 

Bosutti A, Zanconati F, Grassi G, Dapas B, Passamonti S, Scaggiante B. Epigenetic and miRNAs dysregulation in prostate cancer: the role of nutraceuticals. Anti-Cancer Agents Med Chem - Anti-Cancer Agents. 2016;16:1385–402.

CAS  Google Scholar 

Lall RK, Syed DN, Adhami VM, Khan MI, Mukhtar H. Dietary polyphenols in prevention and treatment of prostate cancer. Journal [serial on the Internet]. 2015;16(2):3350–76.

CAS  PubMed Central  Google Scholar 

Anjaly K, Tiku AB. MicroRNA mediated therapeutic effects of natural agents in prostate cancer. Mol Biol Rep. 2021;48:5759–73.

CAS  PubMed  Google Scholar 

Izzo S, Naponelli V, Bettuzzi S. Flavonoids as epigenetic modulators for prostate cancer prevention. Nutrients. 2020;12:1010.

CAS  PubMed  PubMed Central  Google Scholar 

Rajendran P, Abdelsalam SA, Renu K, Veeraraghavan V, Ben Ammar R, Ahmed EA. Polyphenols as potent epigenetics agents for cancer. Int J Mol Sci. 2022;23:11712.

CAS  PubMed  PubMed Central  Google Scholar 

Xiao Y, Xiao X, Zhang X, Yi D, Li T, Hao Q, et al. Mediterranean diet in the targeted prevention and personalized treatment of chronic diseases: evidence, potential mechanisms, and prospects. EPMA J. 2024;15:207–20.

PubMed  Google Scholar 

Mazurakova A, Samec M, Koklesova L, Biringer K, Kudela E, Al-Ishaq RK, et al. Anti-prostate cancer protection and therapy in the framework of predictive, preventive and personalised medicine — comprehensive effects of phytochemicals in primary, secondary and tertiary care. EPMA J. 2022;13:461–86.

PubMed  PubMed Central  Google Scholar 

Golubnitschaja O, Kapinova A, Sargheini N, Bojkova B, Kapalla M, Heinrich L, et al. Mini-encyclopedia of mitochondria-relevant nutraceuticals protecting health in primary and secondary care—clinically relevant 3PM innovation. EPMA J. 2024;15:163–205.

PubMed  PubMed Central  Google Scholar 

Kucera R, Pecen L, Topolcan O, Dahal AR, Costigliola V, Giordano FA, et al. Prostate cancer management: long-term beliefs, epidemic developments in the early twenty-first century and 3PM dimensional solutions. EPMA J. 2020;11:399–418.

PubMed  PubMed Central  Google Scholar 

Crigna AT, Samec M, Koklesova L, Liskova A, Giordano FA, Kubatka P, et al. Cell-free nucleic acid patterns in disease prediction and monitoring—hype or hope? EPMA J. 2020;11:603–27.

PubMed  PubMed Central  Google Scholar 

Ellinger J, Alajati A, Kubatka P, Giordano FA, Ritter M, Costigliola V, et al. Prostate cancer treatment costs increase more rapidly than for any other cancer—how to reverse the trend? EPMA J. 2022;13:1–7.

CAS  PubMed  PubMed Central  Google Scholar 

Chen JF, Yan Q. The roles of epigenetics in cancer progression and metastasis. Biochem J. 2021;478:3373–93.

CAS  PubMed  Google Scholar 

Murr R. Interplay between different epigenetic modifications and mechanisms. Adv Genet. 2010;70:101–41.

CAS  PubMed  Google Scholar 

Constantin N, Sina AA, Korbie D, Trau M. Opportunities for early cancer detection: the rise of ctDNA methylation-based pan-cancer screening technologies. Epigenomes. 2022;6:6.

CAS